These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1235476)

  • 21. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.
    Koziol DE; Holland PV; Alling DW; Melpolder JC; Solomon RE; Purcell RH; Hudson LM; Shoup FJ; Krakauer H; Alter HJ
    Ann Intern Med; 1986 Apr; 104(4):488-95. PubMed ID: 3006567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-A, Non-B hepatitis virus: identification of a core antigen-antibody system that cross reacts with hepatitis B core antigen and antibody.
    Trépo C; Vitvitski L; Hantz O
    J Med Virol; 1981; 8(1):31-47. PubMed ID: 6795310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of antibody to e antigen to precipitate Dane particles containing DNA polymerase activity and hepatitis B core antigen.
    Takahashi K; Yamashita S; Imai M; Miyakawa Y; Mayumi M
    J Gen Virol; 1978 Mar; 38(3):431-6. PubMed ID: 632810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation.
    Möller B; Hopf U; Stemerowicz R; Henze G; Gelderblom H
    Hepatology; 1989 Aug; 10(2):179-85. PubMed ID: 2744730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
    Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relevance of HBe/anti-HBe system and DNA polymerase activity in chronic hepatitis-B virus carriers on haemodialysis. A prospective study.
    Marchesini G; Zoli M; Angiolini A; Feliciangeli G; Santoro A; Ferroni P; Zanetti AR
    Nephron; 1981; 29(1-2):44-8. PubMed ID: 7329473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Markers of type B viral hepatitis].
    Brunello F; Emanuelli G; Camussi G
    Minerva Med; 1979 Sep; 70(41):2791-800. PubMed ID: 386166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors.
    Roque-Afonso AM; Feray C; Samuel D; Simoneau D; Roche B; Emile JF; Gigou M; Shouval D; Dussaix E
    Gut; 2002 Jan; 50(1):95-9. PubMed ID: 11772974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
    Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
    PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The detection of HBV DNA with polymerase chain reaction in blood donors with isolated hepatitis B core antibody.
    Tas T; Kaya S; Onal S; Kucukbayrak A
    Med Glas (Zenica); 2012 Aug; 9(2):227-30. PubMed ID: 22926355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure.
    Abdelmalek MF; Pasha TM; Zein NN; Persing DH; Wiesner RH; Douglas DD
    Liver Transpl; 2003 Dec; 9(12):1253-7. PubMed ID: 14625824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z; Milani S; Sharifi Z
    Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of Hepatitis B Surface Antibody in Addition to Hepatitis B Core Antibody Confers Protection Against Hepatitis B Virus Infection in Hepatitis B Surface Antigen-negative Patients Undergoing Kidney Transplantation.
    Jeon JW; Kim SM; Cho H; Baek CH; Kim H; Shin S; Kim YH; Han DJ; Kim SB
    Transplantation; 2018 Oct; 102(10):1717-1723. PubMed ID: 29621059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological study of the association between hepatocyte damage and HBc antigen.
    Suzuki H; Sata M; Ono K; Hino T; Nakano H; Aritaka T; Tanikawa K
    Kurume Med J; 1992; 39(2):65-75. PubMed ID: 1405434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus core antigen (HBc Ag) accumulation in an HBV nonproducer clone of HepG2-transfected cells is associated with cytopathic effect.
    Roingeard P; Romet-Lemonne JL; Leturcq D; Goudeau A; Essex M
    Virology; 1990 Nov; 179(1):113-20. PubMed ID: 2171201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-core antibody in HBsAg negative subjects].
    Ferroni P; Quartodipalo ME; Zanetti AR
    Boll Ist Sieroter Milan; 1978 Nov; 57(5):676-9. PubMed ID: 556542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
    Dodson SF; Bonham CA; Geller DA; Cacciarelli TV; Rakela J; Fung JJ
    Transplantation; 1999 Oct; 68(7):1058-61. PubMed ID: 10532552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.